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Abstract
Background: Reductions in physical activity (PA) are common throughout young adulthood and low PA is
associated with weight gain. The SNAP Trial previously reported that two self-regulation approaches to weight gain
prevention reduced weight gain over a 2-year period in 18–35 year olds. Presented here are secondary analyses
examining changes in PA and the relationship between PA and weight change over 2 years.
Methods: 599 young adults (age: 27.4 ± 4.4 yrs.; BMI: 25.4 ± 2.6 kg/m2) were randomly assigned to 1 of 3 treatment
arms: Small Changes (reduce calorie intake by 100 kcals/day & add 2000 steps/day), Large Changes (lose 2.3–4.5 kg
initially & increase PA to ≥250 min/wk), or Self-guided (control condition). Small and Large Changes received 10,
face-to-face group sessions (months 1–4), and two 4-week refresher courses each subsequent year. Body weight
and PA were objectively-measured at baseline, 4 months, 1 and 2 years. Daily steps and bout-related
moderate-to-vigorous intensity PA (MVPA: ≥3 METs, ≥10-min bouts) was calculated.
Results: Changes in bout-related MVPA and daily steps did not differ among treatment groups over the 2-year
period (p’s > 0.16). Collapsed across groups, participants gaining >1 lb. (n = 187; 39.6%) had smaller changes in
bout-related MVPA at 4 months, 1 and 2 years relative to those maintaining or losing weight (≤1 lb. weight gain; n
= 282, 60.4%, p’s < 0.05). Averaged across time points, this difference equated to 47.8 min/week. Those gaining and
not gaining >1 lb. did not differ on daily steps (p’s > 0.10). Among participants engaging in ≥250 min/wk. of MVPA
at 2 years (n = 181), 30% gained >1 lb. from baseline to 2 years, which was not different from those engaging in
150–250 min/wk. (n = 87; 36%; p = 0.40), but this percentage was significantly lower when compared to those
engaging in <150 min/wk. (n = 176; 49%; p < 0.001).
Conclusions: On average, PA differences were not observed between young adults assigned to small or large
changes self-regulation interventions to prevent weight gain. Regardless of group assignment, higher levels of MVPA
were associated with better weight gain prevention over 2 years. Our data suggest that achieving >150 min/week of
MVPA is needed for weight gain prevention and that increasing MVPA, rather than steps, should be targeted.
Trial registration: www.clinicaltrials.gov (NCT01183689). Registered Aug 13, 2010.
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Background
Previous literature demonstrates that young adults (ages
18–35) experience a faster rate of weight gain than other
age groups, gaining an average of 1 lb./year [1, 2]. This
is of concern given that rapid weight gain among young
adults has been linked to elevated cardiovascular disease
risk factors and other adverse health outcomes [3]. Of
additional concern is that a higher BMI earlier in life is
associated with having a higher BMI later in life [4, 5].
Thus preventing weight gain throughout young adult-
hood could have significant public health implications.
Young adulthood is also marked by reductions in physical
activity (PA), which typically begin during adolescence and
continue throughout young adulthood. This is a highly tran-
sitional period, often characterized by significant life events
(e.g., starting a new job, getting married, or having children);
thus it is possible that these major life transitions may be a
contributing factor to the observed decrease in PA [6, 7] and
subsequent weight gain [8, 9]. Currently, the role of PA in
weight gain prevention among young adults is not currently
understood. According to the American College of Sports
Medicine, there is adequate evidence that 150–250 min/
week of moderate-to-vigorous intensity PA (MVPA) is suffi-
cient to prevent significant weight gain in the general popu-
lation [10]. Given that weight gain is most common in
young adults, it is unclear whether this magnitude of PA is
also sufficient for preventing weight gain in this age group.
To date, the body of literature related to PA and weight
gain among young adults is limited. The majority of studies
have been cross-sectional (i.e., comparing PA patterns in
young adults to other age groups) or longitudinal (i.e., exam-
ining changes in PA over time within a cohort of individuals)
[7, 11–13] and few intervention studies have been con-
ducted. Thus, little is known about how PA and body weight
change within the context of a lifestyle intervention or
whether changes in PA are related to changes in body weight
among young adults. An additional concern is that the ma-
jority of PA studies have utilized self-reported measures of
PA, which are prone to participant biases due to social desir-
ability or imprecise recall [14]; thus it is unclear whether
similar findings would be observed when objective PA mea-
sures were used. Given these significant gaps in the literature,
coupled with the high risk nature of weight gain among this
demographic group, it is evident that well-designed interven-
tion studies aimed at increasing PA and preventing weight
gain are needed. Studies such as these are critical for
determining whether objectively-assessed PA is improved as
a result of lifestyle intervention in young adults and whether
changes in PA are related to changes in body weight.
The Study of Novel Approaches to Weight Gain Preven-
tion (SNAP) trial overcomes some of these previous limita-
tions and provides an excellent opportunity to examine the
relationship between objectively-assessed PA and weight
change over a 2-year period among young adults interested
in weight gain prevention. The SNAP trial compared two
self-regulation weight gain prevention programs (e.g., ‘Large
Changes’ and ‘Small Changes’) to a minimal contact control
condition (i.e., ‘Self-Guided’) over a two-year period. The pri-
mary aim was to examine changes in weight across the three
intervention arms, and these data have been previously pub-
lished [15]. The current analyses focus on whether there was
a differential effect of intervention arm on objectively-
assessed PA over the 2-year period and whether compliance
to the PA recommendations differed by group. Secondary
aims were to examine the impact of baseline PA on changes
in PA over time and to determine whether there is a rela-
tionship between PA and weight gain prevention over the
intervention period.
Methods
Participants
Young adults (n = 599) interested in weight gain preven-
tion enrolled in the SNAP trial between August 2010 and
February 2012. Participants were recruited primarily by
mass mailings (38%) and emails (23%), using text that
sought individuals who were concerned about gaining
weight over time [16]. Participants were normal weight
(BMI: 21 to <25 kg/m2) or overweight (BMI: 25 to 30 kg/
m2), between the ages of 18 and 35, English speaking, and
had no medical conditions that would limit their ability to
make dietary or PA changes. Eligible individuals were re-
quired to pass screening and baseline assessment visits.
Full exclusion criteria have been previously reported [17].
Design
The SNAP trial examined two novel interventions for
weight gain prevention compared to a control condition in
young adults. Participants were randomized to one of three
treatment arms: Small Changes (SC), Large Changes (LC)
or Self-Guided (SG), which served as the control condition.
Participants in LC and SC received a lifestyle intervention
for 4 months (10 face-to-face group meetings), followed
each year by two four-week refresher courses delivered
primarily via the Internet. A detailed description of these
treatment groups has been reported previously [17] and
intervention components are also summarized below. All
groups completed assessment visits at baseline, 4 months,
1 year, and 2 years post-treatment. Informed consent was
obtained from all participants, and procedures were
performed in accordance with The Miriam Hospital’s
(Providence, RI) and University of North Carolina (Chapel
Hill, NC) Institutional Review Boards.
Randomization
Randomization assignment used variable block lengths, was
stratified by clinical site, sex, and ethnicity (non-Hispanic
white/other), and was implemented through a web-based
data management system.
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Treatment groups
Intervention components common to both large changes
and small changes
Participants randomized to LC or SC attended weekly in-
person, group-based sessions for 8 weeks, followed by 2
monthly sessions, and were offered two 4-week, online re-
fresher courses for each successive year of the study. While
dietary and PA recommendations differed between SC and
LC, both treatment groups emphasized daily self-weighing
and participants were instructed to record their weight
daily throughout the course of the study. Self-regulation
techniques, such as detecting small changes in weight as
soon as they occur and implementing problem solving and
behavioral strategies to counteract the weight gain, were
used in both groups.
Small changes
Participants randomized to SC were instructed to make
daily, small changes in diet and PA in order to prevent
weight gain. Dietary recommendations focused on reducing
calorie intake by 100 cal per day through ‘small’ behavior
modifications, such as reducing portion sizes or selecting
lower calorie alternatives. Further, SC participants were
given pedometers and instructed to increase daily steps by
2000 steps/day above their baseline level (equivalent to 1
mile of walking) through changes in lifestyle activities (e.g.,
parking further from the store or using the stairs). Partici-
pants were given a monthly chart to record their daily
weight, steps, and whether they made any small changes to
their diet. This was completed daily during the first
16 weeks and during refresher courses. These were
reviewed by interventionists and feedback was provided.
Large changes
Participants randomized to LC were instructed to make lar-
ger changes to their diet and PA to create a 5 to 10 pound
buffer against future weight gain within the first 4 months
[18]. Participants were instructed to reduce calorie intake by
500–1000 kcals/day (depending upon initial body weight)
and increase PA gradually to ≥250 min/week of MVPA.
Once this ‘buffer’ was created, participants were instructed
to gradually increase calorie intake to maintain their reduced
weight and to maintain this high level of PA throughout the
remainder of the study. If at any point a participant’s weight
exceeded their baseline weight, it was recommended that
they return to their initial calorie intake and recreate another
5–10 lb. buffer. Participants were instructed to record their
weight, diet, and minutes of PA daily. These diaries were
reviewed by an interventionist and feedback was provided.
Self-guided (control condition)
Participants in the control condition attended one in-person
group session and were provided with general information
on weight gain in young adults, which included basic
guidelines for self-weighing and a brief overview of both SC
and LC approaches. They were then encouraged to select
the approach that would work best for them and apply these
strategies over the course of the study. Participants were sent
quarterly newsletters via postal mail and were provided with
links to internet resources via a study website but received
no additional contact from intervention staff.
Assessments
All assessments were completed by masked staff members,
who were centrally trained and certified.
Anthropometric
Height and weight were measured at baseline, 4 months,
1 year, and 2 years. Height was measured using a wall-
mounted stadiometer and weight was measured in light
clothing without shoes on a calibrated scale.
Dietary intake
Dietary intake was assessed at baseline, 4 months, and
2 years using the Block Food Frequency Questionnaire
[19]. Dietary comparisons between treatment arms will
be reported in a separate manuscript. However, total
daily caloric intake and percentage of total calories from
dietary fat were controlled for in all analyses which
assessed the relationship between PA and weight change.
Physical activity
Physical activity was assessed using the previously validated
Sensewear Armband (SWA, BodyMedia, Pittsburgh, PA)
[20–22]. The SWA is worn on the back of the upper arm
and assesses PA using a biaxial accelerometer and a
combination of heat sensors. Participants were instructed to
wear the device during all waking hours (except while bath-
ing or swimming) for 7 consecutive days at each assessment
time point and data were considered to be ‘valid’ if wear time
was ≥8 h on ≥4 days. Proprietary algorithms produced
minute-by-minute estimates of energy expenditure
(expressed as metabolic equivalents or METs) using the Sen-
sewear Professional Software (Version 7.0). These MET
values were used to calculate ‘bout-related’ moderate-to-
vigorous intensity PA (MVPA), which includes activities ≥3.0
METs and ≥10 min in duration. Further the SWA provided
estimates of daily steps. The proportion of participants meet-
ing the national PA recommendation for improved health
(e.g., ≥150 min/week of bout-related MVPA [23]), weight
control (≥250 min/week of bout-related MVPA [10]), and
daily steps (10,000 steps/day [24]) were also examined.
Statistical analyses
Data were analyzed between May 2016 and February 2017.
Statistical analyses were performed using SAS (version 9.4).
The type I error rate was fixed at 0.05 (two-tailed). Descrip-
tive statistics included mean and standard deviation (SD) or
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median and interquartile range (IQR) for continuous mea-
sures, depending on the normality of distribution, and
count and percentage for categorical variables.
To examine differences among the three treatment groups
in the changes of daily steps, bout-related MVPA, and body
weight, separate mixed effects models were fit to the changes
from baseline in these outcomes, with three time points
(4 months, 1- and 2- years). Each model was adjusted for the
following covariates: clinic, gender, race (White vs. non
White), and baseline value of the corresponding outcome.
Both mixed effects models for the changes of daily steps and
bout-related MVPA also adjusted for the time-varying covari-
ate of armband wear time. Significance of treatment group,
time, and treatment group by time interaction effects were
assessed in these models using the unstructured dependence
structure. Results from the mixed model analyses were pre-
sented as the least square mean with 95% confidence interval.
Dichotomous outcomes were defined over time for meeting
≥250 min/week of bout-related MVPA and for increasing
daily steps by ≥2000 steps/day. Subsequently, these dichotom-
ous outcomes were modeled using the generalized estimating
equations (GEE) approach, adjusting for covariates of clinic,
gender, race (White vs. non White), armband wear time, and
baseline value of either bout-related MVPA or daily steps.
The Wilcoxon rank sum test was used to test the
differences in changes in daily steps and bout-related
MVPA between two groups: those who gained >1 lb. and
those who gained ≤1 lb. or lost weight from baseline to
2 years. A binary indicator variable (= 1 if gained >1 lb.
from baseline to 2 years, =0 otherwise) was added to the
mixed effects models described above. This model also ad-
justed for dietary intake covariates (total daily caloric intake
and percentage of total calories from dietary fat). Regres-
sion coefficient, standard error, and p-value for the binary
indicator are presented in Table 3.
Results
Participants
Subject characteristics have been described in detail previ-
ously [17]. At baseline, four participants failed to meet the
minimal armband wear time criteria, resulting in analysis
sample of n = 595. Participants were predominately white
(73%) and female (78%), 27.7 ± 4.4 years of age, with a
mean BMI of 25.4 ± 2.6 kg/m2. Participants with weight
data and those meeting the minimal armband wear time
threshold at each time point were included in the analyses
(baseline: 99%, 4 months: 92%, 1 year: 79%, 2 years: 76%
of participants) and retention rates did not differ by
treatment arm at any time point (p’s > 0.08, see Appendix
1 Consort diagram and Additional file 1: checklist). Com-
pliance to wearing the armband was excellent at baseline
(7.1 ± 0.9 days for 14.1 ± 1.5 h/day) and remained high at
4 months (6.6 ± 1.3 days for 13.7 ± 1.8 h/day), 1 year (6.6
± 1.4 days for 13.7 ± 1.8 h/day) and 2 years (6.6 ± 1.4 days
for 13.6 ± 1.6 h/day). On average, study participants were
highly active at baseline with 60.2% achieving ≥150 min/
week of bout-related MVPA, 40.8% achieving ≥250 min/
week of bout-related MVPA, and 28.4% averaging the na-
tional recommendation for daily steps (≥10,000 steps/
day). Attendance at face-to-face intervention meetings did
not differ between SC (86.0%) and LC (87.4%).
Change in physical activity throughout the intervention
by treatment arm
The primary aim was to examine whether there was a dif-
ferential effect of treatment arm on objectively-assessed
PA over the 2-year period. The group by time interaction
effect was not significant, indicating that the pattern of
change over time for both daily steps and bout-related
MVPA did not differ between treatment arms (Table 1).
Further, in models adjusting for demographic variables, 4-
month, 1-year, and 2-year change in daily steps and bout-
related MVPA did not significantly differ across treatment
groups. However, there was a significant time effect such
that, when collapsed across treatment arms, changes in
daily steps at month 4 was significantly greater than
changes at year 1 (p = 0.015) and year 2 (p = 0.006), while
changes in weekly bout-related MVPA was significantly
greater at 4 months compared to year 1 (p = 0.013).
Compliance to the intervention PA recommendations for
LC (≥250 min/week of bout-related MVPA) and SC (in-
crease steps by ≥2000 steps/day) was also assessed within
treatment arms. The percentage of participants engaging in
≥250 min/week of bout-related MVPA did not change over
the 2-year intervention period and did not differ between
treatment groups (Table 2). Further, the percentage of par-
ticipants increasing their steps by ≥2000 steps/day above
baseline did not change over time or differ by treatment
arm (Table 2). Finally, attendance at intervention meetings
was not associated with the change in daily steps or change
in MVPA at any time point (e.g., 1-year: SC: steps: r = 0.10,
p = 0.24, MVPA: r = −0.05, p = 0.57; or 1-year LC steps: r =
0.09, p = 0.23, MVPA: 0.14, p = 0.07).
Effect of baseline physical activity on change in physical
activity over time
Given that the mean PA levels at baseline were high (>
250 min/week), a secondary aim was to examine whether
there was an effect of baseline PA on the change in PA over
time and to determine whether this differed by treatment
arm. After adjusting for gender, race, and armband wear
time, baseline PA significantly predicted the 2-year change in
PA. Those with lower bout-related MVPA at baseline had
more favorable changes in bout-related MVPA across the
2-year period (β = −0.38, p < 0.001). For example, averaged
across treatment arms, participants engaging in <250 min/
week of bout-related MVPA at baseline (n = 352) increased
MVPA at 4 months (N = 335, 97.3 ± 186.9 min/week), 1 year
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(N = 287, 72.8 ± 182.7 min/week), and 2 years (N = 274,
98.0 ± 251.3 min/week), while those engaging in ≥250 min/
week at baseline (n = 243) had reductions in MVPA at each
of these time points (4 mo: N = 228, −32.9 ± 295.4, 1 year:
N = 208, −75.6 ± 340.9, 2 years: N = 200, −73.5 ± 444.8 min/
week). Similarly, those with lower daily steps at baseline
had more favorable changes in daily steps from baseline to
2 years (β = −0.42, p < 0.001). The effect of baseline PA on
the change in PA over time was similar in the 3 treatment
arms (daily steps: p = 0.59; MVPA: p = 0.29).
Effect of physical activity on weight change over time
Another aim was to examine the relationship between PA
and weight change across the intervention period. Although
the SNAP primary outcome paper has already reported on
changes in body weight across treatment arms [15], weight
data for the current sample are shown in Table 1. We com-
pared daily steps and bout-related MVPA among partici-
pants gaining >1 lb. from baseline to 2 years (n= 187) to
those who lost weight or gained ≤1 lb. over this same time
period (n= 285). Participants with a 2-year weight gain >1 lb.
engaged in less bout-related MVPA at 4 months, 1 year and
2 years, compared to those not gaining >1 lb. over this time
period (Table 3). Further mixed effects models, adjusting for
demographic variables, treatment group, dietary intake, and
baseline values, revealed the change in MVPA across all time
points differed by an average of 47.8 min/week between
those gaining >1 lb. and those who did not (p= 0.0125).
There was no significant difference in daily steps at 4 months,
1 year, or 2 years between those gaining >1 lb. and those
gaining ≤1 lb. at year 2 (p’s > 0.10).
To further investigate the relationship between change in
PA and change in weight, we used a categorical approach,
examining how different patterns of PA change between
4 months (i.e., the end of the intensive intervention phase)
to 2 years were related to weight change over this same
time period. Participants were categorized into 1 of 4 PA
groups based upon their achievement of ≥250 min/week of
bout-related MVPA at 4 months and 2 years: 1) ‘Non-
adopt’: <250 min/week at 4 months and 2 years, 2) ‘Late
adopt’: <250 min/week at 4 months, but ≥250 min/week at
2 years, 3) ‘Maintain’: ≥250 min/week at 4 months and
2 years, and 4) ‘Non-maintain’: ≥250 min/week at 4 months
but <250 min/week at 2 years (Fig. 1a). Similar categories
were formed using the SC daily step goal, stratifying partici-
pants based upon whether they had a ≥ 2000 steps/day in-
crease from baseline at both 4 months and 2 years (Fig. 1b).
There was a significant group x time interaction effect for
bout-related MVPA category on weight change over time
(p = 0.0002). Independent of 4-month MVPA levels, partici-
pants engaging in <250 min/week at 2 years (‘Non-adopt’
and ‘Non-maintain’ groups) regained all of their weight
from 4 months to 2 years, while those engaging in
≥250 min/week at Year 2 (‘Late adopt’ and ‘Maintain’
groups) had a mean weight loss of 1.5–2.0 kg at Year 2.
There was not a significant group x time interaction effect
when participants were categorized based upon steps.
Finally, we explored whether engagement in ≥250 min/
week of bout-related MVPA (n = 181) was associated with
more favorable changes in weight at 2 years, compared to
150 to <250 (n= 87) and 0–150 min/week (n = 176). Two-
year weight change among participants engaging in
≥250 min/week (−1.83 ± 4.24 kg) was not significantly differ-
ent from those engaging in 150 to <250 min/week (−0.78 ±
4.84 kg; p = 0.11) but was significantly greater than those en-
gaging in 0–150 min/week (−0.06 ± 4.69 kg; p= 0.0001). Of
note, <150 and 150 to <250 min/week groups were not sig-
nificantly different from one another (p = 0.11). Further,
30.4% of participants engaging in ≥250 min/week gained
>1 lb. at year 2, which was significantly lower than the
49.4% observed in the 0–150 min/week group (p= 0.0002),
but not significantly different from those engaging in 150 to
<250 min/week at year 2 (35.6%; p= 0.40). This percentage
was also significantly higher in the 150 to <250 group,
relative to the <150 min/week group (p= 0.03).
Discussion
The SNAP trial examined the effectiveness of two different
self-regulation approaches to weight gain prevention, rela-
tive to a control condition, in a large cohort of young
adults. The primary outcome paper focused on changes in
weight [15] – here we examine whether changes in
objectively-assessed PA differed by treatment arm. Overall,
the change in daily steps and bout-related MVPA over two
years did not differ among SC, LC, or SG. When collapsed
Table 2 Percentage of participants meeting intervention PA recommendations
Assessment Periods p-values
Treatment Group Baseline 4 months 1 year 2 years Treatment Group Time Treatment Group x Time
≥250 min/week of bout-related MVPA Control 81 (40.3%) 83 (43.2%) 65 (40.0%) 63 (41.5%) 0.2949 0.4872 0.1460
Small Change 74 (37.2%) 82 (45.6%) 67 (44.7%) 56 (37.6%)
Large Change 88 (45.1%) 98 (55.4%) 65 (40.9%) 71 (46.7%)
Increase daily steps by ≥2000 steps/day Control – 32 (16.7%) 25 (15.3%) 31 (20.4%) 0.1859 0.5124 0.8087
Small Change – 44 (24.4%) 39 (26.0%) 34 (22.8%)
Large Change – 40 (22.6%) 35 (22.0%) 32 (21.1%)
N (%); Models adjusted for clinic, gender, race, armband wear time, and baseline value of outcome measure
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across treatment arms, the greatest improvement in PA
was observed at 4 months. On average, participants in-
creased bout-related MVPA by 50 min/week, which given
the high PA levels observed at baseline, equated to over
300 min/week of bout-related MVPA at Month 4.
To date, few studies have examined changes in PA
among young adults within the context of a lifestyle inter-
vention and the SNAP trial was the first to examine this
within a weight gain prevention trial. The IDEA study
assessed the effect of a standard behavioral weight loss
program for overweight and obese young adults on
changes in objectively-assessed PA over 6 months [25].
Study participants were given an exercise goal of 300 min/
week of MVPA. While IDEA participants were less active
than SNAP participants at baseline (100 min/week vs.
263 min/week of bout-related MVPA), IDEA participants
significantly increased bout-related MVPA to 215 min/
week at 6 months. While the current study also reported
increases in MVPA, although to a lesser degree than the
IDEA study, SC and LC intervention approaches were no
more effective at increasing MVPA than the SG group. Al-
though we can’t say with certainty why the 3 groups did
not differ on changes in PA, we hypothesize that this may
be attributed to the fact that PA was only a small compo-
nent of the SC or LC interventions. Specifically, only 1 of
the 8 initial weekly intervention sessions in SC and LC fo-
cused on PA. Conversely, SG participants were provided
with an overview of the principles of both the LC and SC
approaches at one intervention session and encouraged to
select whichever approach they felt would be most effect-
ive for them. Therefore, they were given the same gen-
eral instructions for increasing PA as SC and LC,
possibly explaining why similar changes in PA were
observed between treatment groups. These findings
suggest that for individuals enrolled in a program to
prevent weight gain and who are taught that it is im-
portant to increase PA to achieve this goal, will do
so, at least temporarily.
A secondary aim of this study was to examine the rela-
tionship between PA and weight change within the con-
text of an intervention. While changes in PA were
associated with changes in weight, this relationship did
not differ by treatment group. We previously reported that
a ≥ 1 lb. weight gain was associated with worsened cardio-
metabolic outcomes compared to weight loss or <1 lb.
weight gain [26]. Given the clinical significance of gaining
>1 lb., this paper examined whether there were differences
in PA between these post-hoc weight groupings. Partici-
pants who lost weight or gained ≤1 lb. at year 2 had a
59 min/week increase in MVPA above baseline levels at
year 2, while those participants who gained >1 lb. had a
34 min/week decrease in MVPA; differences in bout-
related MVPA between these post-hoc weight groups were
also observed at 4 months and 1 year. These results
remained after adjusting for dietary intake. Interestingly,
there was no difference in daily steps between those who
gained >1 lb. and those who did not. This suggests that
more structured exercise of at least moderate intensity
may be more important than lifestyle activities for
preventing weight gain; thus weight gain prevention
programs should consider targeting changes in bout-
related MVPA.
In addition to looking at differences in PA by post-hoc
weight change groups, we also examined whether achieve-
ment of ≥250 min/week of MVPA was associated with
weight change. While the percentage of participants
achieving this threshold of PA at all time points did not
differ by treatment group, when collapsed across treat-
ment groups, achievement of ≥250 min/week at Year 2
was associated with improved 2-year weight outcomes
when compared to those achieving <250 min/week. More-
over, this association persisted, regardless of bout-related
MVPA at 4 months or dietary intake. However, follow-up
analyses revealed that those achieving ≥250 min/week at
Fig. 1 a Title: Categorization of participants based upon achievement of
≥250 min/week at 4 months and 2 years. a Legend: ‘Non-adopt’:
<250 min/week at 4 months and 2 years; ‘Late adopt’: <250 min/week at
4 months, but ≥250 min/week at 2 years; ‘Maintain’: ≥250 min/week at
4 months and 2 years; ‘Non-maintain’: ≥250 min/week at 4 months but
<250 min/week at 2 years. Model adjusts for clinic, gender, race, dietary
intake, baseline weight, and baseline PA. b Title: Categorization of
participants based upon achievement of ≥2000 steps/day above baseline
at 4 months and 2 years. b Legend: Non- adopt: <2000 step increase
above baseline at 4 months and 2 years; Late Adopt: <2000 step increase
above baseline at 4 months but >= 2000 step increase at 2 years;
Maintain: > = 2000 step increase above baseline steps at 4 months and
2 years; Non-maintain: > = 2000 step increase above baseline at 4 months
and <2000 step increase above baseline at 2 years. Model adjusts for clinic,
gender, race, dietary intake, baseline weight, and baseline steps
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year 2 lost approximately 1 kg (2.3 lbs) more than those
engaging in 150 to <250 min/week of MVPA, which was
not statistically significant. These data suggest that PA
levels ≥150 min/week are also effective for preventing
weight gain. This level of PA is consistent with recom-
mendations from the American College of Sports Medi-
cine for weight gain prevention, which state that there is
sufficient evidence that 150–250 min/week of MVPA is
sufficient to prevent weight gain greater than 3% in most
adults [10]. The current findings confirm this recommen-
dation in a sample of young adults, and expand upon this
recommendation through the use of objective PA moni-
tors, versus self-report measures of PA. Thus future
weight gain prevention efforts in young adults should tar-
get ≥150 min/week of MVPA.
Unlike bout-related MVPA, achievement of ≥10,000
steps/day was not associated with weight change. While
daily steps encompass both light intensity and MVPA, it
appears that bout-related MVPA may be the greatest con-
tributor for preventing weight gain. However, it should be
noted that a greater percentage of SNAP participants
achieved and maintained the MVPA threshold for PA than
those who achieved and maintained ≥10,000 steps/day.
Thus it is possible that achievement of a different thresh-
old of daily steps may be more closely related to weight
change.
Overall, SNAP participants were highly active at base-
line – mean MVPA levels were >250 min/week and over
40% of participants met this threshold of PA. It is unclear
whether this magnitude of PA is common for young
adults of this BMI, or whether young adults enrolling in a
weight gain prevention trial may be more likely to engage
in higher levels of PA. Unfortunately, few studies have
objectively-assessed MVPA among young adults. Over-
weight and obese young adults participating in a weight
loss study (IDEA Study), engaged in >150 fewer min/week
compared to SNAP participants at baseline [25]; however
it is uncertain how much of this difference can be attrib-
uted to differences in BMI between study participants.
Similarly in a population-based study, Tucker et al. re-
ported that only 10.8% of young adults aged 20–29 engage
in an ‘adequate’ amount of MVPA according to guidelines;
however obese individuals were also included in these esti-
mates [6]. Therefore, whether baseline PA among SNAP
participants is ‘typical’ of young adults in this BMI range
cannot be determined.
The final aim of this study was to examine the effect of
baseline PA on change in PA over time. Baseline PA was a
significant moderator of change in PA, with higher base-
line PA associated with less favorable changes in PA over
the intervention period. For example, participants in the
current study who engaged in <250 min/week at baseline
increased PA by approximately 100 min/week at 4 months
while those with PA levels ≥250 min/week at baseline
reduced PA by an average of 33 min/week. This suggests
that self-regulation approaches for weight gain prevention
used in the current study can effectively increase PA
among those with lower levels of PA at baseline; however
additional intervention strategies may be needed within
the context of weight gain prevention programs in order
to promote maintenance of PA in those with high baseline
levels. This is an important and interesting area of
research which warrants further investigation, particu-
larly given that PA is typically reduced throughout
young adulthood, and our findings which demon-
strated that a reduction in PA between months 4 and
24 was associated with weight gain. Novel strategies
for promoting the maintenance of PA in this popula-
tion should be explored given that the PA prescrip-
tions used in the current study led to small
reductions in PA among highly active individuals.
This study answers a novel research question related to
weight gain prevention in young adults and has numerous
strengths including a large sample size and unique popula-
tion. It is further strengthened by the fact that it was ad-
dressed within a randomized trial, it included long-term
follow-up data, and PA was assessed objectively and not
via self-report measures. However, it is not without limita-
tions. It is possible that the findings from this study would
not be generalizable to the entire young adult population
given that study participants may have been more moti-
vated or health conscious, contributing to their decision
to enroll in a weight gain prevention trial. Further, study
participants were highly active, and predominately female
and white. Finally, the findings highlighting the relation-
ship between PA and weight change were performed post-
hoc and thus future studies should be designed to exam-
ine the optimal dose of PA for weight gain prevention.
Conclusions
In conclusion, this study suggests that both Small
Changes (prescribed to increase steps by 2000 steps/day)
and Large Changes (prescribed to increase bout-related
MVPA to ≥250 min/week) PA recommendations led to
similar increases in bout-related MVPA and daily steps,
yet these changes were no different than those observed
in the Self-guided group. This suggests that a brief inter-
vention with general PA recommendations, as provided
to Self-guided participants, may be sufficient for increas-
ing PA at least temporarily among a group of active
young adults who are concerned about weight gain.
Moreover, study findings indicate that regardless of
group assessment, better weight gain prevention over
2 years is associated with higher levels of bout-related
MVPA, but not daily steps. Therefore, future weight gain
prevention interventions should consider targeting bout-
related MVPA and not daily steps.
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Fig. 2 Flow of participants through the study
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